203 related articles for article (PubMed ID: 18498286)
1. Immunohistochemical and ultrastructural characterization of brain tumors in S100beta-v-erbB transgenic rats.
Yokoo H; Tanaka Y; Nobusawa S; Nakazato Y; Ohgaki H
Neuropathology; 2008 Dec; 28(6):591-8. PubMed ID: 18498286
[TBL] [Abstract][Full Text] [Related]
2. [Analysis of S100beta-v-erbB transgenic rats prone to brain tumors].
Yokoo H; Tanaka Y; Nobusawa S; Nakazato Y; Ohgaki H
Brain Nerve; 2009 Jul; 61(7):765-72. PubMed ID: 19618853
[TBL] [Abstract][Full Text] [Related]
3. Brain tumors in S100beta-v-erbB transgenic rats.
Ohgaki H; Kita D; Favereaux A; Huang H; Homma T; Dessen P; Weiss WA; Kleihues P; Heppner FL
J Neuropathol Exp Neurol; 2006 Dec; 65(12):1111-7. PubMed ID: 17146284
[TBL] [Abstract][Full Text] [Related]
4. Expression of oligodendrocyte lineage genes in oligodendroglial and astrocytic gliomas.
Riemenschneider MJ; Koy TH; Reifenberger G
Acta Neuropathol; 2004 Mar; 107(3):277-82. PubMed ID: 14730454
[TBL] [Abstract][Full Text] [Related]
5. Characterization of microglia/macrophages in gliomas developed in S-100β-v-erbB transgenic rats.
Sasaki A; Yokoo H; Tanaka Y; Homma T; Nakazato Y; Ohgaki H
Neuropathology; 2013 Oct; 33(5):505-14. PubMed ID: 23331472
[TBL] [Abstract][Full Text] [Related]
6. Expression of oligodendroglial and astrocytic lineage markers in diffuse gliomas: use of YKL-40, ApoE, ASCL1, and NKX2-2.
Rousseau A; Nutt CL; Betensky RA; Iafrate AJ; Han M; Ligon KL; Rowitch DH; Louis DN
J Neuropathol Exp Neurol; 2006 Dec; 65(12):1149-56. PubMed ID: 17146289
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical characterization of spontaneous and acrylonitrile-induced brain tumors in the rat.
Kolenda-Roberts HM; Harris N; Singletary E; Hardisty JF
Toxicol Pathol; 2013 Jan; 41(1):98-108. PubMed ID: 22821367
[TBL] [Abstract][Full Text] [Related]
8. Quantitative analysis of mitotic Olig2 cells in adult human brain and gliomas: implications for glioma histogenesis and biology.
Rhee W; Ray S; Yokoo H; Hoane ME; Lee CC; Mikheev AM; Horner PJ; Rostomily RC
Glia; 2009 Apr; 57(5):510-23. PubMed ID: 18837053
[TBL] [Abstract][Full Text] [Related]
9. Ultrastructural characterization of transitional cells in oligodendrogliomas.
Kros JM; de Jong AA; van der Kwast TH
J Neuropathol Exp Neurol; 1992 Mar; 51(2):186-93. PubMed ID: 1538242
[TBL] [Abstract][Full Text] [Related]
10. Genetic determinants of malignancy in a mouse model for oligodendroglioma.
Weiss WA; Burns MJ; Hackett C; Aldape K; Hill JR; Kuriyama H; Kuriyama N; Milshteyn N; Roberts T; Wendland MF; DePinho R; Israel MA
Cancer Res; 2003 Apr; 63(7):1589-95. PubMed ID: 12670909
[TBL] [Abstract][Full Text] [Related]
11. Oligodendroglial tumors. An immunohistochemical and electron microscopic study.
Sarkar C; Roy S; Tandon PN
Cancer; 1988 May; 61(9):1862-6. PubMed ID: 3355979
[TBL] [Abstract][Full Text] [Related]
12. Relevance of combinatorial profiles of intermediate filaments and transcription factors for glioma histogenesis.
Colin C; Virard I; Baeza N; Tchoghandjian A; Fernandez C; Bouvier C; Calisti A; Tong S; Durbec P; Figarella-Branger D
Neuropathol Appl Neurobiol; 2007 Aug; 33(4):431-9. PubMed ID: 17442061
[TBL] [Abstract][Full Text] [Related]
13. GFAP-positive neoplastic astrocytes in spontaneous oligodendrogliomas and mixed gliomas of rats.
Nagatani M; Yamakawa S; Saito T; Ando R; Hoshiya T; Tamura K; Uchida K
Toxicol Pathol; 2013; 41(4):653-61. PubMed ID: 23076037
[TBL] [Abstract][Full Text] [Related]
14. The oligodendroglial lineage marker OLIG2 is universally expressed in diffuse gliomas.
Ligon KL; Alberta JA; Kho AT; Weiss J; Kwaan MR; Nutt CL; Louis DN; Stiles CD; Rowitch DH
J Neuropathol Exp Neurol; 2004 May; 63(5):499-509. PubMed ID: 15198128
[TBL] [Abstract][Full Text] [Related]
15. [An immunohistochemical and ultrastructural study of 243 gliomas with reference to the prognosis].
Bian XW
Zhonghua Bing Li Xue Za Zhi; 1992 Jun; 21(3):171-3. PubMed ID: 1335846
[TBL] [Abstract][Full Text] [Related]
16. Angiocentric glioma: report of clinico-pathologic and genetic findings in 8 cases.
Preusser M; Hoischen A; Novak K; Czech T; Prayer D; Hainfellner JA; Baumgartner C; Woermann FG; Tuxhorn IE; Pannek HW; Bergmann M; Radlwimmer B; Villagrán R; Weber RG; Hans VH
Am J Surg Pathol; 2007 Nov; 31(11):1709-18. PubMed ID: 18059228
[TBL] [Abstract][Full Text] [Related]
17. PDGF autocrine stimulation dedifferentiates cultured astrocytes and induces oligodendrogliomas and oligoastrocytomas from neural progenitors and astrocytes in vivo.
Dai C; Celestino JC; Okada Y; Louis DN; Fuller GN; Holland EC
Genes Dev; 2001 Aug; 15(15):1913-25. PubMed ID: 11485986
[TBL] [Abstract][Full Text] [Related]
18. Phenotypic characteristics of GFAP-positive oligodendroglial tumours. Part II: ultrastructural study.
Matyja E; Taraszewska A; Nagańska E; Zabek M
Folia Neuropathol; 2001; 39(2):103-10. PubMed ID: 11680631
[TBL] [Abstract][Full Text] [Related]
19. Well-differentiated pediatric glial neoplasms with features of oligodendroglioma, angiocentric glioma and dysembryoplastic neuroepithelial tumors: a morphological diagnostic challenge.
Keser H; Barnes M; Moes G; Lee HS; Tıhan T
Turk Patoloji Derg; 2014; 30(1):23-9. PubMed ID: 24448703
[TBL] [Abstract][Full Text] [Related]
20. Time dependent alterations of co-localization of S100beta and GFAP in the MPTP-treated mice.
Himeda T; Watanabe Y; Tounai H; Hayakawa N; Kato H; Araki T
J Neural Transm (Vienna); 2006 Dec; 113(12):1887-94. PubMed ID: 16736245
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
